SRPL Completes Annual Report Filings, Seeks Revocation of Trading Suspension
Shree Ram Proteins Limited has completed the submission of its Annual Reports for FY 2023-24 and FY 2024-25 on February 11, 2026. The company is also filing a compounding petition for the delay in its Annual General Meeting. SRPL has requested the revocation of its trading suspension.
The announcement addresses the trading suspension, and its resolution will have a significant impact on the company's stock liquidity and investor confidence.
The company has completed the necessary regulatory filings, which is a positive step towards resolving the trading suspension.
Shree Ram Proteins Limited (SRPL) has informed the National Stock Exchange (NSE) that it has completed the compliance requirements under Regulation 34 of SEBI (LODR) Regulations, 2015, by submitting its Annual Reports for FY 2023-24 and FY 2024-25 through the NEAPS portal.
The company had faced suspension of trading in its securities due to non-compliance with the submission of Annual Reports for two consecutive financial years. The submissions for both FY 2023-24 and FY 2024-25 were made on February 11, 2026, under NEAPS Application Numbers 29227 and 29228, respectively.
Furthermore, SRPL is in the process of filing a compounding petition under Section 441 of the Companies Act, 2013, to address the delay in holding the Annual General Meeting for the aforementioned financial years. The company has enclosed the acknowledgments of submission for both annual reports. In light of these compliances, SRPL has requested the NSE to revoke the suspension of trading in its securities at the earliest.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.